Cargando…

Effect of long term inhaled corticosteroid therapy on adrenal suppression, growth and bone health in children with asthma

BACKGROUND: Inhaled corticosteroids (ICS) are the most effective treatment for children with persistent asthma. However adverse effects of ICS on Hypothalamo Pituitary Adrenal (HPA) axis, growth and bone metabolism are a concern. Hence the primary objective of this study was to describe the effects...

Descripción completa

Detalles Bibliográficos
Autores principales: KWDA, Anuradha, GLDC, Prematilake, BAUI, Batuwita, KASR, Kannangoda, US, Hewagamage, S, Wijeratne, Kantha, Lankatilake, KSH, de Silva
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6829958/
https://www.ncbi.nlm.nih.gov/pubmed/31684902
http://dx.doi.org/10.1186/s12887-019-1760-8
_version_ 1783465679674933248
author KWDA, Anuradha
GLDC, Prematilake
BAUI, Batuwita
KASR, Kannangoda
US, Hewagamage
S, Wijeratne
Kantha, Lankatilake
KSH, de Silva
author_facet KWDA, Anuradha
GLDC, Prematilake
BAUI, Batuwita
KASR, Kannangoda
US, Hewagamage
S, Wijeratne
Kantha, Lankatilake
KSH, de Silva
author_sort KWDA, Anuradha
collection PubMed
description BACKGROUND: Inhaled corticosteroids (ICS) are the most effective treatment for children with persistent asthma. However adverse effects of ICS on Hypothalamo Pituitary Adrenal (HPA) axis, growth and bone metabolism are a concern. Hence the primary objective of this study was to describe the effects of long term inhaled corticosteroid therapy (ICS) on adrenal function, growth and bone health in children with asthma in comparison to an age and sex matched group of children with asthma who were not on long term ICS. Describing the association between the dose of ICS and duration of therapy on the above parameters were secondary objectives. METHOD: Seventy children with asthma on ICS and 70 controls were studied. Diagnosis of asthma in selected patients was reviewed according to the criteria laid down by GINA 2018 guidelines. The estimated adult heights were interpreted relative to their Mid Parental Height (MPH) range. Serum calcium, alkaline phosphatase and vitamin D levels were analyzed in both groups and cortisol value at 30 min following a low dose short synacthen test was obtained from the study group. The average daily dose of ICS (Beclamethasone) was categorized as low, medium and high (100–200, 200–400, > 400 μg /day) respectively according to published literature. RESULTS: Heights of all children were within the MPH range. There was no statistically significant difference in the bone profiles and vitamin D levels between the two groups (Ca: p = 0.554, vitamin D: p = 0.187) but vitamin D levels were insufficient (< 50 nmol/l) in 34% of cases and 41% of controls. Suppressed cortisol levels were seen in 24%. Doses of ICS were low, medium and high in 56, 32 and 12% of children respectively. The association between adrenal suppression with longer duration of therapy (p < 0.01) and with increasing dose of ICS (p < 0.001) were statistically significant. CONCLUSION: ICS had no impact on the growth and bone profiles but its dose and duration were significantly associated with adrenal suppression.
format Online
Article
Text
id pubmed-6829958
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-68299582019-11-07 Effect of long term inhaled corticosteroid therapy on adrenal suppression, growth and bone health in children with asthma KWDA, Anuradha GLDC, Prematilake BAUI, Batuwita KASR, Kannangoda US, Hewagamage S, Wijeratne Kantha, Lankatilake KSH, de Silva BMC Pediatr Research Article BACKGROUND: Inhaled corticosteroids (ICS) are the most effective treatment for children with persistent asthma. However adverse effects of ICS on Hypothalamo Pituitary Adrenal (HPA) axis, growth and bone metabolism are a concern. Hence the primary objective of this study was to describe the effects of long term inhaled corticosteroid therapy (ICS) on adrenal function, growth and bone health in children with asthma in comparison to an age and sex matched group of children with asthma who were not on long term ICS. Describing the association between the dose of ICS and duration of therapy on the above parameters were secondary objectives. METHOD: Seventy children with asthma on ICS and 70 controls were studied. Diagnosis of asthma in selected patients was reviewed according to the criteria laid down by GINA 2018 guidelines. The estimated adult heights were interpreted relative to their Mid Parental Height (MPH) range. Serum calcium, alkaline phosphatase and vitamin D levels were analyzed in both groups and cortisol value at 30 min following a low dose short synacthen test was obtained from the study group. The average daily dose of ICS (Beclamethasone) was categorized as low, medium and high (100–200, 200–400, > 400 μg /day) respectively according to published literature. RESULTS: Heights of all children were within the MPH range. There was no statistically significant difference in the bone profiles and vitamin D levels between the two groups (Ca: p = 0.554, vitamin D: p = 0.187) but vitamin D levels were insufficient (< 50 nmol/l) in 34% of cases and 41% of controls. Suppressed cortisol levels were seen in 24%. Doses of ICS were low, medium and high in 56, 32 and 12% of children respectively. The association between adrenal suppression with longer duration of therapy (p < 0.01) and with increasing dose of ICS (p < 0.001) were statistically significant. CONCLUSION: ICS had no impact on the growth and bone profiles but its dose and duration were significantly associated with adrenal suppression. BioMed Central 2019-11-05 /pmc/articles/PMC6829958/ /pubmed/31684902 http://dx.doi.org/10.1186/s12887-019-1760-8 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
KWDA, Anuradha
GLDC, Prematilake
BAUI, Batuwita
KASR, Kannangoda
US, Hewagamage
S, Wijeratne
Kantha, Lankatilake
KSH, de Silva
Effect of long term inhaled corticosteroid therapy on adrenal suppression, growth and bone health in children with asthma
title Effect of long term inhaled corticosteroid therapy on adrenal suppression, growth and bone health in children with asthma
title_full Effect of long term inhaled corticosteroid therapy on adrenal suppression, growth and bone health in children with asthma
title_fullStr Effect of long term inhaled corticosteroid therapy on adrenal suppression, growth and bone health in children with asthma
title_full_unstemmed Effect of long term inhaled corticosteroid therapy on adrenal suppression, growth and bone health in children with asthma
title_short Effect of long term inhaled corticosteroid therapy on adrenal suppression, growth and bone health in children with asthma
title_sort effect of long term inhaled corticosteroid therapy on adrenal suppression, growth and bone health in children with asthma
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6829958/
https://www.ncbi.nlm.nih.gov/pubmed/31684902
http://dx.doi.org/10.1186/s12887-019-1760-8
work_keys_str_mv AT kwdaanuradha effectoflongterminhaledcorticosteroidtherapyonadrenalsuppressiongrowthandbonehealthinchildrenwithasthma
AT gldcprematilake effectoflongterminhaledcorticosteroidtherapyonadrenalsuppressiongrowthandbonehealthinchildrenwithasthma
AT bauibatuwita effectoflongterminhaledcorticosteroidtherapyonadrenalsuppressiongrowthandbonehealthinchildrenwithasthma
AT kasrkannangoda effectoflongterminhaledcorticosteroidtherapyonadrenalsuppressiongrowthandbonehealthinchildrenwithasthma
AT ushewagamage effectoflongterminhaledcorticosteroidtherapyonadrenalsuppressiongrowthandbonehealthinchildrenwithasthma
AT swijeratne effectoflongterminhaledcorticosteroidtherapyonadrenalsuppressiongrowthandbonehealthinchildrenwithasthma
AT kanthalankatilake effectoflongterminhaledcorticosteroidtherapyonadrenalsuppressiongrowthandbonehealthinchildrenwithasthma
AT kshdesilva effectoflongterminhaledcorticosteroidtherapyonadrenalsuppressiongrowthandbonehealthinchildrenwithasthma